Suflave Interactions
There are 390 drugs known to interact with Suflave (polyethylene glycol 3350 with electrolytes), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 35 are major, 354 are moderate, and 1 is minor.
- View all 390 medications that may interact with Suflave
- View Suflave alcohol/food interactions (1)
- View Suflave disease interactions (7)
Most frequently checked interactions
View interaction reports for Suflave (polyethylene glycol 3350 with electrolytes) and the medicines listed below.
- acetaminophen / codeine
- acyclovir
- albuterol
- Alcohol (contained in alcoholic beverages) (ethanol)
- amlodipine
- amoxicillin
- amoxicillin / clavulanate
- aspirin
- Aspirin Buffered (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- BuSpar (buspirone)
- buspirone
- butalbital
- cannabis
- celecoxib
- chamomile
- Claritin (loratadine)
- clindamycin
- Cozaar (losartan)
- Creon (pancrelipase)
- cyclobenzaprine
- dapsone
- darifenacin
- diclofenac
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- Tylenol (acetaminophen)
- Xanax (alprazolam)
Suflave alcohol/food interactions
There is 1 alcohol/food interaction with Suflave (polyethylene glycol 3350 with electrolytes).
Suflave disease interactions
There are 7 disease interactions with Suflave (polyethylene glycol 3350 with electrolytes) which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- GI obstruction/perforation
- arrhythmias
- impaired gag reflex
- renal disease
- seizures
More about Suflave (polyethylene glycol 3350 with electrolytes)
- Suflave consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: laxatives
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.